Bliss J - Search Results

1

Activity of IL12 as adjuvant in promoting Th1 and Th2 recall responses.

Wolf SF, Bliss J, Stokes K, Sypek J. Wolf SF, et al. Among authors: bliss j. Res Immunol. 1995 Sep-Oct;146(7-8):486-9. doi: 10.1016/0923-2494(96)83021-5. Res Immunol. 1995. PMID: 8839151 Review. No abstract available.

2

IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.

Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF. Bliss J, et al. J Immunol. 1996 Feb 1;156(3):887-94. J Immunol. 1996. PMID: 8558014

3

Interleukin-12 as vaccine adjuvant. Characteristics of primary, recall, and long-term responses.

Bliss J, Maylor R, Stokes K, Murray KS, Ketchum MA, Wolf SF. Bliss J, et al. Ann N Y Acad Sci. 1996 Oct 31;795:26-35. doi: 10.1111/j.1749-6632.1996.tb52652.x. Ann N Y Acad Sci. 1996. PMID: 8958914 No abstract available.

4

Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response.

Schopf LR, Bliss JL, Lavigne LM, Chung CL, Wolf SF, Sypek JP. Schopf LR, et al. Among authors: bliss jl. Infect Immun. 1999 May;67(5):2166-71. doi: 10.1128/IAI.67.5.2166-2171.1999. Infect Immun. 1999. PMID: 10225870 Free PMC article.

5

Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells.

Thibodeaux DK, Hunter SE, Waldburger KE, Bliss JL, Trepicchio WL, Sypek JP, Dunussi-Joannopoulos K, Goldman SJ, Leonard JP. Thibodeaux DK, et al. Among authors: bliss jl. J Immunol. 1999 Nov 15;163(10):5257-64. J Immunol. 1999. PMID: 10553047

6

Immunoglobulin isotype modulation after administration of IL-12.

Van Cleave V, Wolf S, Murray K, Wiencis A, Ketchum M, Bliss J, Haire T, Resmini C, Maylor R, Alderman E. Van Cleave V, et al. Among authors: bliss j. Adv Exp Med Biol. 1995;383:43-52. doi: 10.1007/978-1-4615-1891-4_6. Adv Exp Med Biol. 1995. PMID: 8644512

7

Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells.

Bozza M, Bliss JL, Dorner AJ, Trepicchio WL. Bozza M, et al. Among authors: bliss jl. J Interferon Cytokine Res. 2001 Jan;21(1):21-30. doi: 10.1089/107999001459123. J Interferon Cytokine Res. 2001. PMID: 11177577

8

Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.

Bozza M, Bliss JL, Maylor R, Erickson J, Donnelly L, Bouchard P, Dorner AJ, Trepicchio WL. Bozza M, et al. Among authors: bliss jl. Hepatology. 1999 Dec;30(6):1441-7. doi: 10.1002/hep.510300616. Hepatology. 1999. PMID: 10573523

9

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.

Trepicchio WL, Ozawa M, Walters IB, Kikuchi T, Gilleaudeau P, Bliss JL, Schwertschlag U, Dorner AJ, Krueger JG. Trepicchio WL, et al. Among authors: bliss jl. J Clin Invest. 1999 Dec;104(11):1527-37. doi: 10.1172/JCI6910. J Clin Invest. 1999. PMID: 10587516 Free PMC article. Clinical Trial.

10

Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level.

Walters IB, Ozawa M, Cardinale I, Gilleaudeau P, Trepicchio WL, Bliss J, Krueger JG. Walters IB, et al. Among authors: bliss j. Arch Dermatol. 2003 Feb;139(2):155-61. doi: 10.1001/archderm.139.2.155. Arch Dermatol. 2003. PMID: 12588221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters